Slendesta No Longer Novel Food in Canada
Slendesta, a potato extract ingredient for weight management, has been given non-Novel Food approval by Canada.
Slendesta, a potato extract ingredient for weight management, has been given non-Novel Food approval by Canada. By no longer being considered a Novel Food, Slendesta may be used in conventional food and beverages at specified inclusion levels, without requiring premarket notification.
“Our customers in Canada will now be able to get to market faster since they don’t need to go through a premarket notification process,” says Linda Fullmer, Kemin’s senior vice presidient of marketing.
Slendesta is produced by Kemin Health LC (Des Moines, IA). The ingredient’s active component, Proteinase Inhibitor II (P12), is derived from U.S.-grown white potatoes and enhances the body’s natural release of cholecystokinin (CCK). CCK is a signaling peptide that, once released, helps induce feelings of satiety.
Slendesta is also not considered a novel food in Europe and has GRAS status in the United States.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
